KYORIN Pharmaceutical Revenue

KYORIN Pharmaceutical had revenue of 34.15B JPY in the quarter ending December 31, 2024, with 5.62% growth. This brings the company's revenue in the last twelve months to 121.55B, up 1.44% year-over-year. In the fiscal year ending March 31, 2024, KYORIN Pharmaceutical had annual revenue of 119.53B with 5.53% growth.

Revenue (ttm)

121.55B

Revenue Growth

+1.44%

P/S Ratio

0.75

Revenue / Employee

59.53M

Employees

2,042

Market Cap

91.46B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	119.53B	6.26B	5.53%
Mar 31, 2023	113.27B	7.74B	7.33%
Mar 31, 2022	105.53B	2.63B	2.56%
Mar 31, 2021	102.90B	-7.08B	-6.44%
Mar 31, 2020	109.98B	-3.64B	-3.20%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,170.61B
Takeda Pharmaceutical Company	4,579.02B
Daiichi Sankyo Company	1,795.99B
HOYA Corporation	837.44B
Otsuka Holdings	2,329.86B
Terumo	1,011.15B
Astellas Pharma	1,867.63B
Olympus	993.33B

Revenue Rankings